12916_2022_2418_MOESM1_ESM.docx (2.12 MB)
Additional file 1 of Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry
journal contribution
posted on 2022-07-06, 04:09 authored by Sidong Li, Xiaojin Gao, Jingang Yang, Haiyan Xu, Yang Wang, Yanyan Zhao, Lu Yin, Chao Wu, Yi Wang, Yang Zheng, Bao Li, Xuan Zhang, Yunqing Ye, Rui Fu, Qiuting Dong, Hui Sun, Xinxin Yan, Yuan Wu, Jun Zhang, Chen Jin, Wei Li, Yuejin YangAdditional file 1: Figure S1. Chinese vertical governmental and administrative model and the three-level hospitals in the CAMI registry. Figure S2. Flow-chart of patients included in this study. Figure S3. Reasons for No Reperfusion Therapy among the Eligible STEMI Patients. Figure S4. Landmark analysis of association of SMuRF status with all-cause mortality to 2 years. Table S1. Definition of study variables. Table S2. Baseline information stratified by the number of standard modifiable risk factors. Table S3. Adjusted Proportions of Evidence-based Medication Use among Patients with First ST-segment Elevation Myocardial Infarction by Number of Cardiovascular Risk Factors. Table S4. Association of SMuRF status with in-hospital, 30-day, and 2-year mortality. Table S5. Sensitivity analysis for the association of SMuRF status with all-cause mortality at 30 days.
